Marketed Drugs Immunomodulation

Immunomodulation Jobs

Find an open position today!

FDA Approves Orencia Production By Celltrion In South Korea

Orencia, a rheumatoid arthritis tretament, manufactured by a Korean biopharmaceutical company in partnership with Bristol-Myers Squibb. by Fabio Ferfoglia, PhD, 02/01/2008




SelectedRegional Immunomodulation Drug Revenues (milion USD)
RITUXIMAB5887.95ROCHE HOLDING LTD2009, Worldwide
INFLIXIMAB4304.0JOHNSON AND JOHNSON2009, Worldwide
TACROLIMUS2051.02ASTELLAS PHARMA INC2009, Worldwide
INTERFERON BETA-1B1748.16BAYER SCHERING PHARMA AG2009, Worldwide
MYCOPHENOLATE MOFETIL1524.46ROCHE HOLDING LTD2009, Worldwide
NATALIZUMAB1059.2ELAN CORP PLC2009, Worldwide
FEXOFENADINE HYDROCHLORIDE1045.33HOECHST MARION ROUSSEL2009, Worldwide
HYDROCORTISONEAug 20, 2010LYNE
TACROLIMUSJul 2, 2010WATSON PHARMACEUTICALS INC
TACROLIMUSJul 2, 2010WATSON PHARMACEUTICALS INC
CARBINOXAMINE MALEATEMay 4, 2010CYPRESS PHARMACEUTICAL INC
CARBINOXAMINE MALEATEMay 4, 2010CYPRESS PHARMACEUTICAL INC
CETIRIZINE HYDROCHLORIDEApr 15, 2010TORRENT PHARMACEUTICALS LTD